Definitive Healthcare (NASDAQ:DH) Price Target Raised to $3.40

by · The Cerbat Gem

Definitive Healthcare (NASDAQ:DH – Get Free Report) had its price target upped by equities research analysts at The Goldman Sachs Group from $3.00 to $3.40 in a report issued on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price suggests a potential downside of 4.09% from the company’s current price.

DH has been the subject of several other reports. Barclays decreased their target price on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating for the company in a research report on Monday, March 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Finally, BTIG Research lowered Definitive Healthcare from a “buy” rating to a “neutral” rating in a research report on Friday. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Definitive Healthcare currently has a consensus rating of “Hold” and a consensus price target of $5.10.

Read Our Latest Research Report on DH

Definitive Healthcare Stock Down 3.9%

DH stock traded down $0.15 during mid-day trading on Monday, hitting $3.55. 501,295 shares of the company were exchanged, compared to its average volume of 830,642. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. Definitive Healthcare has a 1-year low of $2.15 and a 1-year high of $6.27. The firm has a market cap of $382.73 million, a P/E ratio of -1.15, a P/E/G ratio of 4.06 and a beta of 1.48. The firm’s 50 day simple moving average is $2.71 and its 200 day simple moving average is $3.87.

Definitive Healthcare (NASDAQ:DH – Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.03. The business had revenue of $59.19 million during the quarter, compared to analysts’ expectations of $56.20 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. Definitive Healthcare’s revenue was down 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.08 earnings per share. On average, sell-side analysts predict that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Hedge Funds Weigh In On Definitive Healthcare

Several hedge funds have recently made changes to their positions in the company. Irenic Capital Management LP boosted its stake in shares of Definitive Healthcare by 9.2% during the 4th quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company’s stock worth $28,783,000 after acquiring an additional 590,009 shares in the last quarter. Palisade Capital Management LP grew its stake in shares of Definitive Healthcare by 1.3% in the first quarter. Palisade Capital Management LP now owns 2,265,198 shares of the company’s stock worth $6,546,000 after acquiring an additional 29,774 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Definitive Healthcare by 1.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,863,912 shares of the company’s stock worth $7,661,000 after purchasing an additional 23,410 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Definitive Healthcare by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company’s stock valued at $5,231,000 after buying an additional 39,938 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its position in Definitive Healthcare by 3.2% in the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock valued at $3,172,000 after acquiring an additional 23,815 shares during the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

About Definitive Healthcare

(Get Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

See Also